Dr. Tapan Kadia, MD
Claim this profileM D Anderson Cancer Center
About Tapan Kadia, MD
Education:
- Obtained MD from Baylor College of Medicine, Houston, Texas, in 2005.
- Completed Residency in Internal Medicine at The Johns Hopkins Hospital, Baltimore, Maryland (2005-2008).
- Undertook Fellowship in Hematology/Oncology at The University of Texas MD Anderson Cancer Center, Houston, Texas (2008-2011).
Experience:
- Currently serves as a Professor of Medicine and Chief of the Section of Leukemia at The University of Texas MD Anderson Cancer Center.
Area of expertise
Acute Myeloid Leukemia
Tapan Kadia, MD has run 17 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Leukemia
Tapan Kadia, MD has run 6 trials for Leukemia. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
The University Of Texas M.D. Anderson Cancer Center
Clinical Trials Tapan Kadia, MD is currently running
Liposomal Daunorubicin-Cytarabine + Venetoclax
for Acute Myeloid Leukemia
This phase II trial studies how well liposome-encapsulated daunorubicin-cytarabine and venetoclax work in treating participants with acute myeloid leukemia that has come back (relapsed), does not respond to treatment (refractory), or has not been treated (untreated). Drugs used in chemotherapy, such as liposome-encapsulated daunorubicin-cytarabine and venetoclax, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting
1 award
Phase 2
Decitabine + Other Drugs
for Acute Myeloid Leukemia
This phase Ib trial is to find out the side effects and possible benefits of decitabine alone or given together with venetoclax, gilteritinib, enasidenib, or ivosidenib in treating patients with acute myeloid leukemia that is under control (remission). Chemotherapy drugs, such as decitabine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Venetoclax may stop the growth of cancer cells by blocking a protein called Bcl-2 needed for cell growth. Gilteritinib, enasidenib, and ivosidenib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving decitabine alone or together with venetoclax, gilteritinib, enasidenib, or ivosidenib may help to control the disease.
Recruiting
1 award
Phase 1
14 criteria
More about Tapan Kadia, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 24 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments Tapan Kadia, MD has experience with
- Venetoclax
- Decitabine
- Cladribine
- Cytarabine
- APG-2575
- Azacitidine
Breakdown of trials Tapan Kadia, MD has run
Acute Myeloid Leukemia
Leukemia
Myelodysplastic Syndrome
Acute Myelogenous Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tapan Kadia, MD specialize in?
Tapan Kadia, MD focuses on Acute Myeloid Leukemia and Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved HLA patients, or patients who are prior malignancy.
Is Tapan Kadia, MD currently recruiting for clinical trials?
Yes, Tapan Kadia, MD is currently recruiting for 9 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Tapan Kadia, MD has studied deeply?
Yes, Tapan Kadia, MD has studied treatments such as Venetoclax, Decitabine, Cladribine.
What is the best way to schedule an appointment with Tapan Kadia, MD?
Apply for one of the trials that Tapan Kadia, MD is conducting.
What is the office address of Tapan Kadia, MD?
The office of Tapan Kadia, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.